During the past decade, Cossington House Surgery conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cossington House Surgery" are "Herpes Labialis" (1 trials), "Prostate Cancer" (1 trials) and "Wounds" (1 trials). Many other conditions were trialed in "Cossington House Surgery" in a lesser frequency.

Most popular intervention types in "Cossington House Surgery" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acyclovir Lauriad" (1 trials), "Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg" (1 trials), "Decapeptyl® SR 22.5mg" (1 trials), "PICO (single use portable negative pressure wound therapy)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cossington House Surgery" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cossington House Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cossington House Surgery, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cossington House Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".